Pfizer Inc.

NYSE:PFE  
43.88
-0.59 (-1.33%)
5:27:05 PM EDT: $43.91 +0.03 (+0.07%)
Products

FDA Approves Pfizer-Biontech Covid-19 Vaccine

Published: 08/23/2021 14:00 GMT
Pfizer Inc. (PFE) - FDA Approves First Covid-19 Vaccine.
Approved the First Covid-19 Vaccine, Known As the Pfizer-biontech Covid-19 Vaccine.
FDA Says Pfizer-biontech Covid-19 Vaccine Will Now Be Marketed As Comirnaty, for Prevention of Covid-19 Disease in Individuals 16 Years of Age & Older.
Pfizer-biontech Covid-19 Vaccine Also Continues to Be Available Under Eua Including for Individuals 12 Through 15 Years of Age.
Further Company Coverage: [22uay.
De].
((reuters.
Briefs@thomsonreuters.
Com;)).